AstraZeneca PLC (AZNCF)
137.93
+3.98
(+2.97%)
USD |
OTCM |
Sep 22, 16:00
AstraZeneca Price: 137.93 for Sept. 22, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2023 | 137.93 | 137.93 | 137.93 | 137.93 | 416.00 |
| Sep 21, 2023 | 134.80 | 134.80 | 133.95 | 133.95 | 960.00 |
| Sep 20, 2023 | 137.60 | 137.60 | 136.34 | 136.34 | 642.00 |
| Sep 19, 2023 | 133.35 | 133.35 | 130.68 | 130.68 | 857.00 |
| Sep 18, 2023 | 135.50 | 137.84 | 131.45 | 131.45 | 3626.00 |
| Sep 15, 2023 | 138.28 | 138.28 | 138.28 | 138.28 | 800.00 |
| Sep 14, 2023 | 133.00 | 133.00 | 133.00 | 133.00 | 507.00 |
| Sep 13, 2023 | 133.40 | 133.90 | 130.08 | 130.08 | 48397.00 |
| Sep 12, 2023 | 133.17 | 133.17 | 132.22 | 132.22 | 560.00 |
| Sep 11, 2023 | 135.70 | 135.70 | 135.70 | 135.70 | 0.000 |
| Sep 08, 2023 | 135.84 | 135.84 | 135.70 | 135.70 | 1614.00 |
| Sep 07, 2023 | 133.00 | 135.29 | 133.00 | 134.68 | 3379.00 |
| Sep 06, 2023 | 133.90 | 133.90 | 133.90 | 133.90 | 0.000 |
| Sep 05, 2023 | 136.14 | 136.20 | 133.90 | 133.90 | 1171.00 |
| Sep 01, 2023 | 136.00 | 136.00 | 136.00 | 136.00 | 555.00 |
| Aug 31, 2023 | 134.04 | 134.04 | 134.04 | 134.04 | 446.00 |
| Aug 30, 2023 | 139.88 | 139.88 | 136.72 | 136.72 | 971.00 |
| Aug 29, 2023 | 135.60 | 139.10 | 132.50 | 139.10 | 1151.00 |
| Aug 28, 2023 | 135.00 | 136.64 | 135.00 | 136.64 | 1095.00 |
| Aug 25, 2023 | 131.55 | 136.35 | 131.55 | 135.97 | 1642.00 |
| Aug 24, 2023 | 134.96 | 136.00 | 134.96 | 136.00 | 5786.00 |
| Aug 23, 2023 | 136.49 | 139.35 | 136.03 | 139.35 | 3271.00 |
| Aug 22, 2023 | 137.54 | 137.54 | 133.00 | 135.80 | 1699.00 |
| Aug 21, 2023 | 136.25 | 136.95 | 136.25 | 136.95 | 1084.00 |
| Aug 18, 2023 | 136.20 | 136.20 | 135.01 | 136.03 | 7114.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
69.40
Minimum
Jan 28 2019
153.10
Maximum
Apr 24 2023
109.13
Average
110.02
Median
Price Benchmarks
| GSK PLC | 37.43 |
| Adaptimmune Therapeutics PLC | 0.7825 |
| Akari Therapeutics PLC | 3.62 |
| Biodexa Pharmaceuticals Plc | 5.58 |
Price Related Metrics
| PE Ratio | 34.83 |
| PS Ratio | 4.836 |
| Price to Book Value | 5.717 |
| Price to Free Cash Flow | 32.79 |
| Earnings Yield | 2.87% |
| Market Cap | 213.78B |
| Operating PE Ratio | 33.09 |
| Normalized PE Ratio | 38.31 |